Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21

Nov.08.2024
Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21
The Irish Senate has passed the Public Health (Tobacco) (Amendment) Bill, raising the legal minimum age for the sale of tobacco products to 21.

According to Irish Central, on November 7th, the Irish Senate passed the Public Health (Tobacco) (Amendment) Bill for 2024, completing its legislative process in both houses of parliament. The bill will raise the minimum legal age for the sale of tobacco products to 21. The bill is now set to be submitted to the President for review and signing.

 

After the president signs, the law will take effect on February 1, 2028. The transition period before this is designed to ensure individuals currently aged between 18 and 21 who are eligible to purchase tobacco will not be affected.

 

The bill stipulates that current penalties will be expanded to include punishments for selling tobacco products to individuals under the age of 21. First-time offenders can be fined up to a maximum of 4000 euros or face six months in prison, or both.

 

Ireland's Department of Health said that this measure aims to accelerate the decline in adult smoking prevalence, which have remained at 18% for many years, and reduce child smoking rates to zero. 

 

If the bill is passed, Ireland will become the first country in the European Union to raise the legal age for tobacco sales to 21.

 

"Ireland has long been a world leader in tackling smoking, beginning with the workplace smoking ban in 2004 and continuing with a range of measures including restrictions around the sale, advertising and packaging of smoking products to make them less attractive and less available to young people," Ireland's Minister for Health Stephen Donnelly said.

 

"I look forward to seeing this measure enacted, to help our young people to avoid the lifetime of addiction and illness that tobacco smoking brings," he said.

 

Minister of State Colm Burke, responsible for public health and national drug strategy, said: "This measure will protect our young people from starting their adult lives with an addiction to a product that causes 76% of lung cancers here and kills half of those who use it.

 

"I have strongly supported its introduction from the beginning and I look forward to its enactment."

 

Ireland's Chief Medical Officer, Professor Mary Hogan, said: "The enactment of this legislation represents another significant step in our efforts to reduce smoking levels."

 

"Tobacco smoking continues to be the biggest risk factor driving disability and death combined in our country, placing a huge burden on our health service."

 

"This measure will contribute to eliminating that ongoing threat and will support people to follow healthier behaviours."

 

In December 2023, Donnelly commenced section 28 of the Public Health (Tobacco Products and Nicotine Inhaling Products) Act to prohibit the sale of nicotine-inhaling products such as e-cigarettes (commonly referred to as vapes) to persons under 18.

 

In May 2024, Donnelly implemented parts of the bill that banned the sale of tobacco and nicotine inhalation products through vending machines. In December, he signed a law imposing on-the-spot fines of 2,000 euros for the sale of such products to children. 

 

In addition, Northern Ireland Health Minister Mike Nesbitt has welcomed the introduction of the Tobacco and Vapes Bill at Westminster this week. The bill prohibits anyone born on or after January 1, 2009 will never be able to legally be sold cigarettes, but its implementation in Northern Ireland will be subject to the agreement of the NI Executive and support of the NI Assembly.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Namibia Moves to Tighten Laws on E-Cigarettes and Emerging Nicotine Products
Namibia Moves to Tighten Laws on E-Cigarettes and Emerging Nicotine Products
Namibia is moving to tighten regulation of e-cigarettes and other emerging nicotine products as part of broader tobacco control efforts. Deputy health minister Susan Ndjaleka said the government is reviewing the Tobacco Products Control Act to close regulatory gaps and address emerging tobacco products. Namibia is also working toward joining the Protocol to Eliminate Illicit Trade in Tobacco Products in order to curb the black market and protect public revenue.
Apr.17 by 2FIRSTS.ai
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT Chair Luc Jobin told shareholders at the company’s 2026 Annual General Meeting that BAT delivered on its plans in 2025 despite a challenging external environment, with the U.S. business returning to growth, smokeless consumers increasing by more than 15%, improved New Categories contribution, and GBP 6.3 billion returned to shareholders.
Apr.16 by 2FIRSTS.ai
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
According to South Korean media reports, KT&G has expanded sales of its heated tobacco device lil AIBLE 3.0 to convenience stores across Seoul starting May 13. The convenience-store version is offered in the exclusive OUD GRAY color. On the same day, KT&G also launched two new dedicated consumables for the lil AIBLE platform—AIIM REMIX and AIIM ICESPOT—at convenience stores nationwide, each priced at KRW 4,800.
Market
Jun.01